Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells
H.-W. Snoeck, A. Strikoudis, L. Loffredo, Y.-W. Chen
This study uses hPSC-derived 3D lung organoids to model fibrotic lung disease, identifying IL-11 as a potential therapeutic target for IPF and HPSIP.
bioRxiv · Feb 3, 2019Pathology